The Industry Standard: Intelligence for the Information Economy

  September 5, 2001
  NEWS & ANALYSIS
   Headlines
   Money & Markets
   Tech & Telecom
   Media & Marketing
   Metrics & Stats
   Policy & Politics
  SEARCH
   
  advanced search
  SERVICES
   Company Index
   Newsletters
   Wireless
  PRINT EDITION
   Read the Magazine

Home > Company Index > Drugs > Biotechnology-Research > Elitra Pharmaceuticals Inc.

Elitra Pharmaceuticals Inc.
 PROFILE
Elitra Pharmaceuticals is a scum buster. The biotechnology firm is focused on identifying the genes that allow bacteria and fungi to grow and thrive; it uses this information to develop antibiotics and antifungal drugs to treat both common and life-threatening infections, particularly drug-resistant strains. Working with partner Incyte Genomics, Elitra is building a database of microbial sequence data; it has already identified some 2,000 gene drug targets. The company has also teamed with LG Chemical, part of South Korea's LG Group conglomerate, to develop and market treatments for human fungal and bacterial infections. Elitra Pharmaceuticals was founded in 1997.

 COMPETITION
Cubist Pharmaceuticals, Inc. (CBST)
Genelabs Technologies, Inc. (GNLB)
Microcide Pharmaceuticals, Inc. (MCDE)

 FINANCIAL OVERVIEW
Fiscal Year-End: December
1999 Sales (mil.): 0.00
Employees: 48
Revenue per employee: $0.00

 KEY PEOPLE
• Harry F. Hixon
    CEO
• Gregory J. Tibbetts
    CFO

 CONTACT INFO
3510 Dunhill St.
San Diego, CA 92121
US
Phone: 858-410-3030
Fax: 858-410-3090
Online: Web Site

Company Data   News, quotes & more       

Hoovers Online   Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.


ADVERTISEMENT
FEATURED LINKS
Home |  Customer Service |  About Us
Australia |  Brazil |  China |  Korea |  Norway |  Poland |  Sweden |  Taiwan

Copyright ©2001 Standard Media International. Privacy Policy
Stock data provided by Stockpoint and its data suppliers. Copyright © 1995-2001